Completed NA INTERVENTIONAL 2-arm NCT00349973

Clinical Trial of Dipyridamole in Schizophrenia

Sponsor: University of Maryland, Baltimore

Conditions Schizoaffective Disorder Schizophrenia Schizophreniform Disorder

Updated 8 times since 2017 Last updated: Oct 31, 2019 Started: May 31, 2001 Primary completion: Sep 30, 2008 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00349973, this NA trial focuses on Schizoaffective Disorder and Schizophrenia and remains completed. Sponsored by University of Maryland, Baltimore, it has been updated 8 times since 2001, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Dec 2019 — Jan 2021 [monthly]

Completed NA
Sep 2019 — Dec 2019 [monthly]

Completed NA

▶ Show 3 earlier versions

Jan 2019 — Sep 2019 [monthly]

Completed NA
Jun 2018 — Jan 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Maryland, Baltimore

Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States